Total Liabilities

$3.14B

Quarterly · Period ending: Jun 30, 2026 · USD

EW Total Liabilities

Latest reported$3.14Bperiod endingJun 30, 2026

EW Quarterly Total Liabilities ($213.00M → $3.14B)

Quarterly total liabilities

High-resolution chart · PNG

EW total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Edwards Lifesciences Total Liabilities — Quarterly (USD)
Period ending	Total Liabilities (USD)
Jun 30, 2026	3,142,200,000
Mar 31, 2026	2,993,700,000
Dec 31, 2025	3,359,600,000
Sep 30, 2025	3,067,200,000
Jun 30, 2025	2,882,200,000
Mar 31, 2025	2,830,700,000
Dec 31, 2024	2,992,400,000
Sep 30, 2024	3,359,800,000
Jun 30, 2024	2,594,700,000
Mar 31, 2024	2,549,900,000
Dec 31, 2023	2,643,800,000
Sep 30, 2023	2,643,700,000
Jun 30, 2023	2,557,500,000
Mar 31, 2023	2,589,200,000
Dec 31, 2022	2,485,800,000
Sep 30, 2022	2,420,400,000
Jun 30, 2022	2,481,500,000
Mar 31, 2022	2,575,000,000
Dec 31, 2021	2,666,700,000
Sep 30, 2021	2,619,000,000
Jun 30, 2021	2,528,800,000
Mar 31, 2021	2,555,300,000
Dec 31, 2020	2,662,800,000
Sep 30, 2020	2,590,500,000
Jun 30, 2020	2,585,000,000
Mar 31, 2020	2,175,000,000
Dec 31, 2019	2,339,800,000
Sep 30, 2019	2,151,500,000
Jun 30, 2019	2,073,200,000
Mar 31, 2019	2,021,800,000
Dec 31, 2018	2,183,300,000
Sep 30, 2018	2,596,900,000
Jun 30, 2018	2,521,900,000
Mar 31, 2018	2,579,400,000
Dec 31, 2017	2,701,800,000
Sep 30, 2017	2,325,900,000
Jun 30, 2017	2,198,900,000
Mar 31, 2017	2,037,700,000
Dec 31, 2016	1,891,000,000
Sep 30, 2016	1,647,200,000
Jun 30, 2016	1,580,200,000
Mar 31, 2016	1,554,500,000
Dec 31, 2015	1,556,200,000
Sep 30, 2015	1,455,200,000
Jun 30, 2015	1,319,700,000
Mar 31, 2015	1,274,500,000
Dec 31, 2014	1,332,900,000
Sep 30, 2014	1,306,600,000
Jun 30, 2014	1,411,700,000
Mar 31, 2014	1,310,900,000
Dec 31, 2013	1,165,500,000
Sep 30, 2013	1,093,200,000
Jun 30, 2013	759,900,000
Mar 31, 2013	704,600,000
Dec 31, 2012	742,200,000
Sep 30, 2012	659,500,000
Jun 30, 2012	640,500,000
Mar 31, 2012	613,900,000
Dec 31, 2011	642,600,000
Sep 30, 2011	628,300,000
Jun 30, 2011	617,200,000
Mar 31, 2011	573,300,000
Dec 31, 2010	459,000,000
Sep 30, 2010	491,900,000
Jun 30, 2010	524,100,000
Mar 31, 2010	452,900,000
Dec 31, 2009	457,600,000
Sep 30, 2009	497,500,000
Jun 30, 2009	462,000,000
Mar 31, 2009	415,600,000
Dec 31, 2008	521,400,000
Sep 30, 2008	506,700,000
Jun 30, 2008	451,000,000
Mar 31, 2008	532,700,000
Dec 31, 2007	510,100,000
Sep 30, 2007	475,900,000
Jun 30, 2007	444,300,000
Mar 31, 2007	464,200,000
Dec 31, 2006	497,400,000
Sep 30, 2006	512,400,000
Jun 30, 2006	536,800,000
Mar 31, 2006	516,000,000
Dec 31, 2005	539,100,000
Sep 30, 2005	485,800,000
Jun 30, 2005	489,100,000
Mar 31, 2005	475,000,000
Dec 31, 2004	484,600,000
Sep 30, 2004	472,600,000
Jun 30, 2004	503,400,000
Mar 31, 2004	533,600,000
Dec 31, 2003	466,300,000
Sep 30, 2003	492,100,000
Jun 30, 2003	520,700,000
Mar 31, 2003	492,900,000
Dec 31, 2002	468,800,000
Sep 30, 2002	459,600,000
Jun 30, 2002	503,700,000
Mar 31, 2002	479,100,000
Dec 31, 2001	514,000,000
Sep 30, 2001	547,000,000